Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Thomas A Mitro. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Thomas A Mitro har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:AERI / Aerie Pharmaceuticals Inc President and COO 81.418
US:ISTA / Ista Pharmaceuticals Inc VP, Sales & Marketing 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Thomas A Mitro. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Thomas A Mitro som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-02-09 2022-02-08 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.111 81.418 -1,35 7,33 -8.144 596.794
2022-02-09 2022-02-07 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.310 82.529 -1,56 7,24 -9.484 597.510
2022-02-08 2022-02-06 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.435 83.839 -1,68 7,05 -10.117 591.065
2022-02-08 2022-02-04 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.435 85.274 -1,65 7,05 -10.117 601.182
2021-02-25 2021-02-23 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -763 86.709 -0,87 15,66 -11.949 1.357.863
2021-02-09 2021-02-08 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.085 87.472 -1,23 17,72 -19.226 1.550.004
2021-02-09 2021-02-07 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.229 88.557 -1,37 17,68 -21.729 1.565.688
2021-02-09 2021-02-06 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.438 89.786 -1,58 17,68 -25.424 1.587.416
2021-02-08 2021-02-04 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy))
A - Award 62.500 62.500
2021-02-08 2021-02-04 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 14.000 91.224 18,13
2020-05-18 2020-05-16 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -2.345 77.224 -2,95 14,84 -34.812 1.146.390
2020-02-25 2020-02-24 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.027 79.569 -1,27 20,30 -20.848 1.615.251
2020-02-25 2020-02-23 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -763 80.596 -0,94 21,59 -16.473 1.740.068
2020-02-11 2020-02-08 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.183 81.359 -1,43 20,49 -24.240 1.667.046
2020-02-11 2020-02-07 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.307 82.542 -1,56 20,49 -26.780 1.691.286
2020-02-10 2020-02-06 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 62.500 62.500
2020-02-10 2020-02-06 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 14.000 83.849 20,04
2019-05-17 2019-05-16 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -2.345 69.849 -3,25 40,54 -95.066 2.831.678
2019-05-17 2019-05-16 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 13.559 72.194 23,12
2019-04-15 2019-04-12 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.564 58.635 -2,60 41,89 -65.516 2.456.220
2019-02-26 2019-02-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.027 60.199 -1,68 40,18 -41.265 2.418.796
2019-02-26 2019-02-24 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.027 61.226 -1,65 40,04 -41.121 2.451.489
2019-02-26 2019-02-23 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -763 62.253 -1,21 40,04 -30.551 2.492.610
2019-02-11 2019-02-08 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.241 63.016 -1,93 40,39 -50.124 2.545.216
2019-02-11 2019-02-07 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 57.500 57.500
2019-02-11 2019-02-07 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 12.778 64.257 24,82
2018-08-29 2018-08-27 4 AERI AERIE PHARMACEUTICALS INC
Option (Right to Buy)
M - Exercise -7.332 63.498 -10,35
2018-08-29 2018-08-27 4 AERI AERIE PHARMACEUTICALS INC
Option (Right to Buy)
M - Exercise -182.668 126.984 -58,99
2018-08-29 2018-08-27 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -451 51.479 -0,87 61,01 -27.513 3.140.482
2018-08-29 2018-08-27 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -189.549 51.930 -78,50 60,27 -11.423.493 3.129.650
2018-08-29 2018-08-27 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
M - Exercise 7.332 241.479 3,13 3,15 23.096 760.659
2018-08-29 2018-08-27 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
M - Exercise 182.668 234.147 354,84 3,15 575.404 737.563
2018-05-10 2018-02-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.027 51.479 -1,96 53,85 -55.304 2.772.144
2018-05-10 2018-02-24 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.027 52.506 -1,92 53,85 -55.304 2.827.448
2018-05-10 2018-02-23 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -763 53.533 -1,41 53,85 -41.088 2.882.752
2018-04-16 2018-04-12 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.564 54.296 -2,80 53,40 -83.518 2.899.406
2018-04-16 2018-04-12 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 9.040 55.860 19,31
2018-02-12 2018-02-08 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 57.500 57.500
2018-02-12 2018-02-08 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 12.778 46.820 37,54
2017-02-27 2017-02-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.116 34.042 -3,17 44,55 -49.718 1.516.571
2017-02-27 2017-02-24 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.116 35.158 -3,08 44,55 -49.718 1.566.289
2017-02-27 2017-02-23 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 79.418 79.418
2017-02-27 2017-02-23 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 8.824 36.274 32,15
2017-02-27 2016-02-25 5 AERI AERIE PHARMACEUTICALS INC
Common Stock
F - Taxes -1.300 27.450 -4,52 16,34 -21.242 448.533
2016-03-01 2016-02-24 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 71.250 71.250
2016-03-01 2016-02-24 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 11.875 28.750 70,37
2015-02-27 2015-02-25 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 71.250 71.250
2015-02-27 2015-02-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
A - Award 11.875 16.875 237,50
2014-03-17 2014-03-13 4 AERI AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 126.000 126.000
2013-11-01 2013-10-30 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
P - Purchase 5.000 5.000 10,00 50.000 50.000
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -21.014 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -3.986 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -10.060 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -7.940 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -162.747 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -14.966 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -19.271 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -32.570 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -28.115 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -11.504 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -24.646 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -26.842 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -26.629 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -22.256 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Option (right to buy)
D - Sale to Issuer -125.000 0 -100,00
2012-06-15 2012-06-06 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -161.169 0 -100,00 9,10 -1.466.638
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -30.000 0 -100,00 9,08 -272.400
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -15.729 0 -100,00 9,08 -142.819
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -1.115 22.256 -4,77 9,00 -10.035 200.304
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -15.334 0 -100,00 9,08 -139.233
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -21.780 0 -100,00 9,08 -197.762
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -9.862 26.842 -26,87 9,08 -89.547 243.725
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -1.253 0 -100,00 9,08 -11.377
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -21.731 11.504 -65,39 9,08 -197.317 104.456
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
F - Taxes -837 161.169 -0,52 9,08 -7.600 1.463.415
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
M - Exercise 1.115 162.006 0,69 6,82 7.604 1.104.881
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
F - Taxes -3.943 160.891 -2,39 9,08 -35.802 1.460.890
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
M - Exercise 9.862 164.834 6,36 3,63 35.799 598.347
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
F - Taxes -2.489 154.972 -1,58 9,08 -22.600 1.407.146
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
M - Exercise 21.731 157.461 16,01 1,04 22.600 163.759
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
F - Taxes -10.698 135.730 -7,31 9,08 -97.138 1.232.428
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
M - Exercise 21.780 146.428 17,47 4,46 97.139 653.069
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
F - Taxes -12.871 124.648 -9,36 9,08 -116.869 1.131.804
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
M - Exercise 15.729 137.519 12,91 7,43 116.866 1.021.766
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
F - Taxes -11.433 121.790 -8,58 9,08 -103.812 1.105.853
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
M - Exercise 15.334 133.223 13,01 6,77 103.811 901.920
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
F - Taxes -482 117.889 -0,41 9,08 -4.377 1.070.432
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
M - Exercise 1.253 118.371 1,07 3,49 4.373 413.115
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
F - Taxes -28.084 117.118 -19,34 9,08 -255.003 1.063.431
2012-05-23 2012-05-22 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
M - Exercise 30.000 145.202 26,04 8,50 255.000 1.234.217
2012-02-09 2012-02-08 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -1.327 115.202 -1,14 8,15 -10.815 938.896
2012-02-09 2012-02-07 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -1.167 116.529 -0,99 8,17 -9.534 952.042
2012-02-06 2012-02-02 4 ISTA ISTA PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -1.748 117.696 -1,46 8,18 -14.299 962.753
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)